InvestorsHub Logo
Followers 106
Posts 10171
Boards Moderated 0
Alias Born 02/25/2003

Re: None

Sunday, 06/27/2021 7:32:23 PM

Sunday, June 27, 2021 7:32:23 PM

Post# of 1121
$RLFTF $NRXP DD (opinion) by Mt on Yh0 - Maybe not new (June 5th), but if you doubt about our ability to get EUA :

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179120/

"Currently, two available commercial dosage forms of synthetic VIP (Aviptadil in intravenous and inhaled formulation) are under two clinical trials for COVID-19 patients with respiratory failure (clinicaltrials.gov: NCT04311697 and NCT04360096).

Considering all the above-mentioned advantages, besides the exceptional safety profile of VIP and the affordable manufacturing of its synthetic forms, VIP could have the potential as a preventive measure and even therapeutic agent for patients with COVID-19 infection."

Critical covid is only the first step.

~ Money Making Money ~

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News